Fate Therapeutics, Inc.
NASDAQ:FATE
3.87 (USD) • At close September 20, 2024
Overview | Financials
Cijfers zijn in miljoenen (behalve de cijfers per aandeel en de ratio's) USD.
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operationele Activiteiten: | |||||||||||||
| Nettowinst
| -160.928 | -281.721 | -212.151 | -173.387 | -98.149 | -66.598 | -42.952 | -33.462 | -29.992 | -25.883 | -20.894 | -14.239 | -13.427 |
| Afschrijvingen & Amortisatie
| 18.282 | 13.758 | 5.85 | 3.087 | 2.193 | 1.204 | 0.971 | 0.881 | 0.687 | 0.496 | 0.571 | 0.59 | 0.672 |
| Uitgestelde Inkomstenbelasting
| -7.714 | 0 | 5.067 | 1.676 | -0.478 | -0.335 | 0.005 | 0.171 | 0 | 0.003 | 0.026 | 0 | 0.121 |
| Aandelen Gebaseerde Vergoedingen
| 43.459 | 78.733 | 54.364 | 30.753 | 17.41 | 6.293 | 3.606 | 3.184 | 2.4 | 2.434 | 1.554 | 0.155 | 0.172 |
| Verandering in Werkkapitaal
| 19.182 | -34.71 | 2.098 | -12.773 | 3.64 | 1.744 | 2.083 | 1.18 | 0.37 | 0.017 | 0.307 | 0 | 0.343 |
| Vorderingen
| 36.654 | -29.804 | -3.16 | -5.515 | 0.5 | -0.5 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Voorraden
| 0 | 0 | -5.907 | 1.554 | -4.277 | -4.254 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Crediteuren
| -28.94 | 14.252 | 5.907 | -1.554 | 4.277 | 4.254 | 2.511 | 1.561 | 0.477 | 0 | 0 | 0 | 0 |
| Overig Werkkapitaal
| 11.468 | -19.158 | 5.258 | -7.258 | 3.14 | 2.244 | -0.428 | 1.18 | 0.37 | -0.146 | -1.271 | 0 | 0 |
| Overige Niet-Contante Posten
| -44.544 | -24.268 | -18.098 | 111.415 | -7.791 | 19.042 | -0.613 | -1.606 | 8.138 | 0.517 | 3.089 | 0.22 | 0.095 |
| Kasstroom uit Operationele Activiteiten
| -132.263 | -248.208 | -162.87 | -39.229 | -83.175 | -38.65 | -36.905 | -29.823 | -18.397 | -22.419 | -15.373 | -13.274 | -12.145 |
| Investeringsactiviteiten: | |||||||||||||
| Investeringen in Materiële Vaste Activa
| -6.153 | -35.566 | -50.704 | -4.932 | -7.395 | -2.303 | -1.725 | -0.457 | -1.498 | -0.882 | -0.244 | -0.709 | -0.002 |
| Netto Overnames
| -118.818 | -202.317 | 273.319 | 156.144 | 150.058 | 0 | 0 | 0.018 | 0 | 0 | 0 | 0 | 0 |
| Aankoop van Beleggingen
| -358.81 | -404.796 | -968.159 | -277.344 | -248.858 | -55.66 | -39.971 | -19.675 | 0 | 0 | 0 | 0 | 0 |
| Verkoop/verval van Beleggingen
| 477.628 | 607.113 | 694.84 | 121.2 | 98.8 | 57.5 | 31.5 | 16 | 0 | 0 | 0 | 0 | 0 |
| Overige Investeringsactiviteiten
| 118.818 | 202.317 | -273.319 | -156.144 | -150.058 | 1.84 | -8.471 | 0.018 | 0 | 0 | 0.006 | 0 | 0.202 |
| Kasstroom uit Investeringsactiviteiten
| 112.665 | 166.751 | -324.023 | -161.076 | -157.453 | -0.463 | -10.196 | -4.114 | -1.498 | -0.882 | -0.238 | -0.709 | 0.2 |
| Financieringsactiviteiten: | |||||||||||||
| Schuldaflossingen
| 0 | 0 | 0 | 0 | -15 | 0 | -10.764 | -7.689 | -1.546 | -1.75 | -3.679 | -0.25 | -0.8 |
| Uitgifte van Gewone Aandelen
| 0.085 | 9.207 | 453.129 | 282.348 | 162.406 | 137.27 | 43.206 | 28.849 | 36.729 | 0.142 | 40.503 | 0.207 | 0.014 |
| Terugkoop van Gewone Aandelen
| 0 | 0 | 0 | 0 | 2.522 | 2.693 | -0.193 | 0.186 | 0.42 | 0 | 0 | 0 | -0.007 |
| Uitgekeerde Dividenden
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Overige Financieringsactiviteiten
| 0.085 | 9.207 | 453.129 | 282.838 | 149.928 | 140.78 | 15.195 | 36.577 | 0.42 | 19.974 | 23.736 | 16.726 | 7.9 |
| Kasstroom uit Financieringsactiviteiten
| 0.085 | 9.207 | 453.129 | 282.838 | 149.928 | 140.78 | 47.444 | 57.737 | 35.603 | 18.366 | 60.56 | 16.683 | 7.107 |
| Overige Informatie: | |||||||||||||
| Effect van Wisselkoersveranderingen op Kas
| 0.05 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Netto Kasstroomverandering
| -19.463 | -72.25 | -33.764 | 82.533 | -90.7 | 101.667 | 0.343 | 23.8 | 15.708 | -4.935 | 44.949 | 2.7 | -4.838 |
| Kaspositie aan het Einde van de Periode
| 41.87 | 76.56 | 148.81 | 182.574 | 100.041 | 190.741 | 89.074 | 88.609 | 64.809 | 49.101 | 54.036 | 9.087 | 6.387 |